Cartesian Therapeutics Inc - Descartes-15 to Be Assessed in Autoimmune Indications Following Phase 1 Trial
Cartesian Therapeutics Inc - Descartes-15將在完成1期臨床試驗後用於自身免疫性疾病的評估
Cartesian Therapeutics Inc - Descartes-15 to Be Assessed in Autoimmune Indications Following Phase 1 Trial
Cartesian Therapeutics Inc - Descartes-15將在完成1期臨床試驗後用於自身免疫性疾病的評估
譯文內容由第三人軟體翻譯。